Treatment of Candida auris during extracorporeal life support: A case report.
Paul DobryStephanie B EdwinTsz Hin NgKarey DutcheshenAmir KakiTheodore L SchreiberPublished in: The International journal of artificial organs (2024)
With rates of ECMO utilization on the rise, prevention of nosocomial infections is of paramount importance. Candida auris , an emerging highly pathogenic multidrug resistant fungus, is of particular concern as it is associated with persistent colonization of environmental surfaces, inability to be recognized by many diagnostic platforms, inconsistent laboratory susceptibility results, and high mortality rates. We describe a case of C. auris in a VV-ECMO patient successfully managed with a combination of anidulafungin, amphotericin B, and flucytosine.
Keyphrases
- multidrug resistant
- extracorporeal membrane oxygenation
- biofilm formation
- acute respiratory distress syndrome
- candida albicans
- acinetobacter baumannii
- respiratory failure
- klebsiella pneumoniae
- drug resistant
- case report
- pseudomonas aeruginosa
- cardiovascular events
- gram negative
- staphylococcus aureus
- risk factors
- escherichia coli
- coronary artery disease
- cystic fibrosis
- risk assessment
- type diabetes
- mechanical ventilation
- methicillin resistant staphylococcus aureus
- life cycle